Apellis Pharmaceuticals (1JK.STU) Q3 2026 Earnings

30JulConfirmed
Q1 2026
Q2 2026
Next
-0.4
-0.35
-0.29
-0.24

Details

Expected EPS
-0.26567212619999997
Actual EPS
N/A
Surprise EPS
0.27
Surprise Percent
+100%

Description

Apellis Pharmaceuticals (1JK.STU) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts